Efficacy and Safety of IBI-10090 in Ocular Surgery Patients

Completed · Phase 2

Conditions studied: Inflammation Associated With Cataract Surgery

In brief

This study will test the efficacy and safety of IBI-10090 in the treatment of ocular inflammation after ocular surgery.

Key facts

Study ID

NCT01606735

Run by

ICON Bioscience Inc

People needed

172

Starts

2012-04-01

Expected to finish

2013-03-01

Last updated by the study team

2014-09-22

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled for unilateral cataract surgery

You may not qualify if…

• Ocular, topical, or oral corticosteroids within 7 days of Day 0

Where it is running

• Inland Eye Specialists — Hemet, California, United States
• California Eye Professionals — Temecula, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.